Yoga Intervention on Glycemic and Lipid Control

Yoga as an Adjunctive Therapy for Metabolic Dysfunction Associated Steatotic Liver Disease: Evidence from a Randomized Controlled Trial - NA

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110687

Enrollment

Registered

2026-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E784- Other hyperlipidemia

Interventions

Intervention1: yoga: suryanamaskar 5 times vakrasana 2 time both side manduk asana 3 minutes chakki chalan asana 3 minutes tiryak tadasana 5 times trikonasana 10 times both side breathing exercise 10

Eligibility

Inclusion criteria

Inclusion criteria: participants diagnosed with type 2 diabetes mellitus , dyslipidemia according to standard clinical guidlines. indivudal able to perform mild to moderate physical activity and yoga practice. participants providing written informed consent.

Exclusion criteria

Exclusion criteria: Individuals with severe systemic illnesses. Individuals currently practicing regular yoga, meditation, or structured exercise programs within the last 3 6 months. Patients on medications significantly affecting lipid metabolism or glycemic control unless stabilized for a defined duration. Participants with alcohol or substance abuse.

Design outcomes

Primary

Measure	Time frame
fasting blood sugar post-prabdial blood sugar HbA1c LDL HDL VLDL TRIGYCERIDE TOTAL CHOLESTEROLTimepoint: 12 weeks	—

Secondary

Measure	Time frame
Know the imrovement in fatty liverTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Arun Kumar Dwivedi

Banaras Hindu University

arunkd@bhu.ac.in9451050844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026